Wells Fargo Upgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Globus Medical Reports Second Quarter 2016 Results
July 26, 2016 4:30 PM EDTAUDUBON, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the second quarter ended June 30, 2016.
Worldwide sales increased 2.9% as reported to $137.5 million, or 3.1% on a constant currency basisSecond quarter net income increased 7.3% to $25.8 million, or 18.8% of salesDiluted earnings per share (EPS) increased 6.9% to $0.27Non-GAAP diluted EPS increased 10.6% to $0.29Non-GAAP Adjusted EBITDA (AEBITDA) was 36.5% of salesCompany issues new 2016 guidance for sales of $575 millionDavid Paul, Chairman and CEO said, Second quarter sales... More
